CPH 0.00% 0.9¢ creso pharma limited

CPH on it's own were likely going to fail long-term. There...

  1. 2,457 Posts.
    lightbulb Created with Sketch. 1101
    CPH on it's own were likely going to fail long-term. There wasn't much doubt about that (unless management changed which wasn't going to happen).

    However now holders may stand a chance with the new Company in their TRIP share holdings.

    Probably the most positive (and legitimising) thing is William Lay is joining the team.

    Mr. William Lay, previously Associate Director, M&A at Canopy Growth appointed Executive Vice President and Chief Strategy Officer to assist in growth trajectory - Mr. Lay has overseen and/or supported over C$5Bn in cannabis M&A transactions.

    But I agree, the sooner they can get EverBlu out of the picture the better. There's a reason they call it conflicts of interest and why it's a huge no-no in business.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.